BCL2 and benign prostatic hyperplasia: Furthermore, in the phr100 and fina groups, it showed a significant decrease in the anti-apoptotic protein Bcl-2 and an increase in the expression of the pro-apoptotic protein Bax, compared with the BPH group (Figure 6C–E)